GH
CRL icon

GAM Holding’s Charles River Laboratories CRL Stock Holding History

GAM Holding’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,681
Closed -$355K – 611
2019
Q3 		$355K Sell
2,681
-3,249
-55% -$436K 0.02% 682
2019
Q2 		$841K Buy
5,930
+509
+9% +$69K 0.03% 541
2019
Q1 		$787K Buy
5,421
+2,095
+63% +$275K 0.03% 513
2018
Q4 		$372K Sell
3,326
-654
-16% -$81.9K 0.02% 626
2018
Q3 		$535K Buy
3,980
+1,124
+39% +$139K 0.02% 654
2018
Q2 		$321K Sell
2,856
-3,048
-52% -$330K 0.01% 792
2018
Q1 		$630K Sell
5,904
-11,786
-67% -$1.27M 0.02% 569
2017
Q4 		$1.94M Buy
+17,690
New +$1.93M 0.06% 381

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

GAM Holding's CRL Position: Q4 2019 in Review

GAM Holding sold out of Charles River Laboratories (CRL) in Q4 2019, closing a stake of 2,681 shares — an estimated $355K sold.

GAM Holding first reported a position in CRL in Q4 2017 and held it in 8 quarters. The position peaked at $1.94M in Q4 2017. 413 funds tracked by Wall St. Rank hold CRL as of Q4 2019.

  • GAM Holding reported no remaining Charles River Laboratories position as of Q4 2019 after selling out during the quarter.
  • GAM Holding sold 2,681 Charles River Laboratories shares in Q4 2019, an estimated $355K.
  • GAM Holding first reported a position in Charles River Laboratories in Q4 2017 and held it in 8 quarters.
  • GAM Holding's Charles River Laboratories position peaked at $1.94M in Q4 2017.
  • 413 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2019.

Based on GAM Holding's 13F filing for Q4 2019, filed 6 Feb 2020.